Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ramipril for Cardiovascular Risk Reduction (HOPE Tips)
NCT03099213Phase 4Completed
- Sponsor
- Sanofi
- Start
- Nov 2008
- Primary completion
- Apr 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ramipril in cardiovascular disease (CVD), sponsored by Sanofi. Started Nov 2008; status: completed.
02
Drugs
ramipril
03
Conditions
cardiovascular disease (CVD)
Beyond the preview
Go deeper on NCT03099213.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03099213.